Methods. We compared time series of internet searches for "rotavirus" from Google Trends with rotavirus laboratory reports from the United States and United Kingdom and with hospitalizations for acute gastroenteritis in the United States and Mexico. Using time and location parameters, Google quantifies an internet query share (IQS) to measure the relative search volume for specific terms. We analyzed the correlation between IQS and laboratory and hospitalization data before and after national vaccine introductions.
Internet access is expanding rapidly in countries at all income levels. The World Bank has estimated internet use at 87.4, 91.6, and 44.4 users per 100 people in the United States, United Kingdom, and Mexico, respectively [1] . Many internet users use search engines to identify health information; aggregated search data for monitoring disease activity has shown promise and limitations [2] [3] [4] [5] [6] [7] [8] . An example limitation is that users can search for disease terms for reasons other than current illness, and these searches for nonillness reasons might be amplified by transient media coverage and thereby weaken the association between searches and real disease activity.
Rotavirus is the most common cause of severe diarrhea in children worldwide [9] . In countries with a national rotavirus vaccination program, disease burden was reduced dramatically after vaccine implementation [10] . In 1 study, Google internet searches for "rotavirus" were correlated strongly with rotavirus disease activity in the United States and United Kingdom from 2004 to 2010 [11] . However, that time period preceded vaccine introduction in the United Kingdom and included only 2 full US postvaccine rotavirus seasons with reasonable vaccine uptake, which limits our ability to make conclusions about the value of search data for monitoring vaccine impact. Furthermore, that study did not include any middle-income countries, where both internet search behavior and disease-surveillance systems might differ from those in high-income countries.
In this study, we aimed to assess how well Google internet searches capture rotavirus disease trends as a complement to other approaches for monitoring the effect of rotavirus vaccination programs, especially during a period of rapid change after vaccine implementation in countries with different income
Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US. DOI: 10.1093/jpids/pix004 levels, vaccine-introduction dates, and vaccine coverage. We compared internet search data with rotavirus laboratory detection and hospitalizations for acute gastroenteritis (AGE) in the United States, United Kingdom, and Mexico, which implemented a national rotavirus vaccination program in 2006, 2013, and 2007, respectively.
METHODS
We conducted a time-series analysis of internet search and laboratory surveillance data for rotavirus and hospitalization surveillance data for AGE using multiple data sources (detailed later) from the United States, United Kingdom, and Mexico. We measured the correlation between internet search and laboratory or hospitalization data before and after implementation of national rotavirus vaccination programs. Our hypothesis was that disease activity was the main driver of search activity, but we also considered the impact of alternative drivers for internet searches for "rotavirus, " specifically rotavirus vaccine-related news events and norovirus illnesses, which cause a similar clinical syndrome.
Internet Search Data
Internet search volume was estimated using Google Trends internet query shares (IQSs) (www.google.com/trends), which have been used in other studies on disease monitoring [6] . Google Trends summarizes the relative number of Google web searches for a given search term in a specified time and location. Each data point is normalized to the total number of searches within the time and location range it represents, and the resulting values are scaled to range from 0 to 100. Monthly IQSs for "rotavirus" and "rotavirus vaccine" in the United States, United Kingdom, and Mexico for the time period of January 1, 2004, through September 30, 2015, were downloaded on November 13, 2015.
Laboratory Data
National laboratory surveillance data for rotavirus cases and norovirus outbreaks were available for the United States and for England and Wales (approximating disease patterns for the United Kingdom). US rotavirus laboratory data from January 2004 to September 2015 were sourced from 371 laboratories that reported rotavirus tests to the National Respiratory and Enteric Virus Surveillance System (NREVSS). A variety of clinical, state, and county laboratories participate in the NREVSS, and laboratory participation has varied over time. For this reason, we used the proportion of stool samples that tested positive for rotavirus per month as an indicator of rotavirus activity. US norovirus outbreak laboratory data were sourced from CaliciNet, a national surveillance network of federal, state, and local public health laboratories. Launched in 2009, CaliciNet collects genetic sequence data on laboratory-confirmed norovirus outbreaks (2 or more norovirus-positive samples) that are reported to 29 state and local health departments across the United States.
Rotavirus and norovirus laboratory data for England and Wales from January 2004 to September 2015 were sourced from LabBase2 (which became the Second Generation Surveillance System [SGSS] in December 2014), a well-established laboratory reporting system that routinely collects data from laboratories around the United Kingdom on specimens that test positive for any one of many organisms [12] . Using data from this surveillance network, Public Health England publishes weekly rotavirus and norovirus surveillance reports. Because reporting is thought to be relatively consistent over time but negative results are not reported, we used the number of rotavirus-positive test results for analysis.
Hospitalization Data
National hospitalization data for AGE of any etiology were available for the United States and Mexico. All-cause AGE trends have been used to assess the impact of rotavirus vaccine on hospitalizations given the high proportion of this syndrome associated with rotavirus and the lack of standardization in testing and coding for rotavirus across hospital sites [13] [14] [15] . AGE hospitalizations in the United States were sourced from the State Inpatient Databases (SID) of the Healthcare Cost and Utilization Project (HCUP) (maintained by the Agency for Healthcare Research and Quality), which captures hospitalization data from acute care community hospitals [16] . We restricted our analyses to the 31 states that continually reported data to the SID between January 2004 and December 2013, the most current year for which data were available at the time of this analysis; the population covered by the SID represents 76% of the US children younger than 5 years. HCUP SID data were accessed through an active collaboration between the HCUP and the Centers for Disease Control and Prevention. All-cause AGE hospitalizations, including those with a bacterial, parasitic, viral, or undetermined etiology, were identified using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), codes. Per-capita rates were calculated using a previously described methodology [15] by dividing the monthly number of hospitalizations by the number of children younger than 5 years residing in the participating states.
Data on AGE hospitalizations in Mexico from January 2005 (the first year of reliable IQS data for Mexico) to December 2014 were sourced from the National System for Health Informatics, an electronic database for Mexico's Ministry of Health hospitals. Because the catchment populations of the study hospitals were not known, rates of hospitalization for diarrhea per 10 000 all-cause hospitalizations were calculated using the same methodology as that in a previous study of the impact of rotavirus vaccine in Mexico [17] .
Prevaccine and Postvaccine Comparisons
We evaluated differences in internet searches, rotavirus laboratory reports, and AGE hospitalizations before and after vaccine introduction using unpaired-sample t tests. Boundaries for the prevaccine and postvaccine time periods were defined by the months in which rotavirus vaccine was introduced into the national health system in the United Kingdom (July 2013) and Mexico (May 2007) and by the month in which rotavirus vaccine was recommended by the American Academy of Pediatrics in the United States (January 2007). The month in which the vaccine was introduced was excluded from each analysis.
Correlation
We calculated the coefficient of determination (R 2 ) to evaluate how closely laboratory and hospitalization data fit the IQS data for all years, and we stratified for the prevaccine and postvaccine time periods for all 3 countries. We also calculated the R 2 value from multivariable linear regression models to assess the influence of rotavirus vaccine-related searches and norovirus activity (by including the "rotavirus vaccine" IQS and norovirus laboratory data, respectively, as explanatory variables) in the United States and United Kingdom models.
Seasonal Variation
In all 3 countries, vaccine introduction has changed the seasonality of rotavirus infections [17] [18] [19] [20] . To assess if seasonality in rotavirus IQSs was also affected, we compared the ratio of peak IQS (ie, the month with the highest IQS in each season) to the median IQS in each season. A similar peak-to-average ratio was used previously as an indicator of seasonal intensity of rotavirus disease; a higher ratio reflects greater deviation from average and, thus, greater seasonal variation [21] .
RESULTS
We found strong positive correlations between rotavirus IQSs and laboratory data for the United States (R 2 = 0.78) and United Kingdom (R 2 = 0.52) ( Figure 1 and Table 1 ). Similarly, we found strong positive correlations between rotavirus IQSs and AGE hospitalization data for the United States (R 2 = 0.86) and Mexico (R 2 = 0.69) ( Figure 2 and Table 1 ). In all the analyses, correlations were stronger in the prevaccine period (R 2 = 0.83, 0.61, 0.88, and 0.74, respectively) than in the postvaccine period (R 2 = 0.68, 0.28, 0.88, and 0.42, respectively) ( Table 1 ).
In the United States and United Kingdom, months with high norovirus disease activity experienced high rotavirus IQSs despite low laboratory detection of rotavirus (Figure 3 ). Correlations improved with the additions of rotavirus vaccine IQSs and norovirus disease activity in both the United States and United Kingdom ( Table 1) .
The mean monthly US rotavirus IQS decreased from 36.4 to 25.3 after vaccine introduction, a 30.5% (95% confidence interval [CI], 12.9%-48.1%; P = .0008) reduction (Table 2) . Similarly, the rotavirus IQS decreased from 32.7 to 10.7 in Mexico after vaccine introduction, a 67.4% (95% CI, 52%-83%; P < .0001) reduction. The rotavirus IQS increased in the United Kingdom after vaccine introduction, but this increase was not statistically significant (7.3% [95% CI, 10.1% decrease to 24.7% increase]; P = .41).
Seasonal variations in rotavirus IQSs decreased markedly after vaccine introduction in all 3 countries; we found lower peak/median IQS ratios in postvaccine seasons than in the prevaccine seasons (Figure 4 ). In the United Kingdom, the median IQS increased after vaccine introduction, compared to decreases in the median IQS in the United States and Mexico.
CONCLUSIONS
Internet searches for "rotavirus, " as measured by Google Trends IQSs, correlated well with laboratory-confirmed rotavirus disease in the United States and United Kingdom and with AGE hospitalizations in the United States and Mexico. Consistent with decreased rotavirus disease activity after the introduction of national rotavirus vaccination programs, there were declines in the IQSs during peak rotavirus seasons in all 3 countries.
In each country, lower correlations between rotavirus IQSs and disease activity were found after vaccine introduction. This finding is explained most likely by internet searches for rotavirus motivated by reasons other than illness, such as queries related to vaccination, that are not likely to be seasonal, resulting in relatively elevated IQSs in months of low disease activity. Additional alternative motives for internet searches include rotavirus vaccine-related news events and norovirus outbreaks; adding these inputs improves the postvaccine correlation to nearly match the prevaccine correlation in the United States and United Kingdom.
In the United States, the correlation between rotavirus IQSs and AGE hospitalizations was stronger than that between the IQSs and rotavirus laboratory detection The stronger correlation with hospitalizations might be a result of higher specificity for rotavirus disease with laboratory testing than with AGE hospitalizations and rotavirus IQSs. The difference in specificity is evidenced by variability in monthly values that is more similar for rotavirus IQSs and AGE hospitalizations than with laboratory detection. The amplitudes (maximum/minimum value ratio) for rotavirus IQSs and AGE hospitalizations were 9 and 8 (911:115 per 100 000), respectively, whereas for the rotavirus test-positive proportion, the amplitude was 45 (0.45:0.01). The trends in activity were similar for all 3 variables, but the higher variability for the more specific measure of laboratory testing contributed to the lower correlation with the less specific measure of internet searches. We found several outlier monthly IQSs that were likely attributable to news items related to rotavirus vaccines and not disease. On March 22, 2010, the media reported that the US Food and Drug Administration suspended the use of Rotarix after researchers found porcine circovirus genetic material in the vaccines [22] . On November 12, 2012, the United Kingdom announced that rotavirus vaccine would be added to its national program the following summer. Those months (March 2010 for United States and November 2012 for United Kingdom) had extremely high rotavirus IQS scores despite the low level of disease activity, which negatively affected the correlation results. Postvaccine correlations between rotavirus IQSs and rotavirus disease were lowest in the United Kingdom (0.28) and Mexico (0.42). In the United Kingdom, rotavirus IQSs did not decline after vaccine introduction, despite a decline in laboratory detection of rotavirus. This divergence was driven, in part, by searches for rotavirus vaccine, as indicated by the improved correlation when the rotavirus vaccine IQS was added to the model. We also suspect that many vaccine-motivated rotavirus searches did not include "vaccine" in the search term. Although overall searches for rotavirus did not decline, the seasonal intensity of IQSs diminished considerably, consistent with a loss of seasonality in laboratory detection of rotavirus after vaccine introduction.
In Mexico, the low postvaccine correlation between rotavirus IQSs and AGE hospitalizations might be a result of alternative etiologies of AGE hospitalization (ie, bacterial enteritis) that are seen more commonly in low-and middle-income countries than in high-income countries [23] . This explanation is supported by the observation that annual peaks in AGE hospitalizations in Mexico changed between the fall-winter seasons before vaccine introduction, when rotavirus was predominant, and the spring-summer seasons after vaccine introduction, when rotavirus was rare [17, 20] . Models for AGE hospitalizations that included IQSs for the bacterial pathogens Shigella and Salmonella (data not shown) resulted in weak individual correlations and did not improve on models with the rotavirus IQS alone. In contrast, the postvaccine correlation between US rotavirus IQSs and AGE hospitalizations remained strong (0.88), because nonrotavirus etiologies of AGE hospitalizations are less common [15, 24, 25] .
Our study had several limitations related to how time-series data might not reflect disease activity. Changes in laboratory testing practices might have affected the rotavirus and norovirus laboratory data from the United States and United Kingdom. Changes in nonrotavirus gastroenteritis disease could have affected hospitalization data. Google Trends data could have been affected by changes in who had internet access over time, the type of information available on the internet, and/or the type of information for which people searched during the study time period. Another limitation is generalizability to other countries; differences in internet access according to socioeconomic strata, internet search behavior, and rotavirus testing practices might exist.
In conclusion, the results of our study suggest that internet searches can approximate rotavirus disease activity, although results should be contextualized by considering competing search motivations. Internet searches can complement, but not replace, other surveillance approaches for monitoring the impact of rotavirus vaccination programs. Our findings are made more robust by revealing similar results across 3 different countries using both laboratory and epidemiologic measures of disease activity and similar changes after the introduction of rotavirus vaccination programs. Furthermore, divergences in internet search and disease activities can be adjusted for retrospectively in models that consider variables that prompt similar searches, but media events that garner public attention can limit the use of these approaches in real time. Continued worldwide growth in internet access adds promise to the role of big data sources, including internet search, social media, and commercial activities, as a complement to traditional disease surveillance, especially given its low cost, timeliness, and ease of use. 
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